• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Allopurinol for asymptomatic hyperuricemia associated with hypersensitivity reactions

byJames JiangandAndrew Cheung, MD MBA
July 21, 2015
in Chronic Disease, Endocrinology, Nephrology
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Between 2005 and 2011, the percentage of patients from the Taiwanese National Health Insurance database who received allopurinol for asymptomatic hyperuricemia increased significantly. In the same time period, the rate of hypersensitivity conditions attributed to allopurinol also increased significantly.

2. In patients with renal or cardiovascular comorbidities, allopurinol use for asymptomatic hyperuricemia was associated with statistically significant increased risk of hypersensitivity reactions and mortality.

Evidence Rating Level: 2 (Good)       

Study Rundown: Allopurinol has been a mainstay of treatment for gouty arthropathy, uric acid nephrolithiasis, and hyperuricemia secondary to cancer or chemotherapy. However, this medication is not without adverse effects, and is associated with hypersensitivity syndromes including, but not limited to, Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Allopurinol is often used in asymptomatic hyperuricemia in patients with renal and cardiovascular comorbidities, as it is thought that high serum uric acid can exacerbate these conditions. This study studied the association of hypersensitivity reactions with allopurinol for asymptomatic hyperuricemia.

This study found that in patients with renal or cardiovascular comorbidities, allopurinol use for asymptomatic hyperuricemia was associated with increased risk of hypersensitivity reactions and mortality. Additional risk factors identified for allopurinol related hypersensitivity reactions included female sex, age greater than 60 years, and allopurinol dose greater than 100 mg/day. Strengths of the study include the large number of patients analyzed. However, the population studied was ethnically homogenous (98% Han Chinese), which may limit its generalizability. Moreover, the results were based on insurance claims data and diagnosis codes, which did not reflect the severity of the hypersensitivity reactions.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Patient values and preferences when treating acute episodic migraine

Anti-VEGF therapy for retinopathy of prematurity may be associated with pulmonary hypertension risk

Relevant Reading: Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012

In-Depth [retrospective cohort]: This retrospective cohort study examined data collected from the Taiwan National Health Insurance Research database, gathered from 2005 to 2011. The study identified new users of allopurinol, which was defined as receiving the medication in the past 3 years. ICD-9 codes were identified for hypersensitivity conditions, including dermatitis due to medicines, erythema multiforme, SJS, TEN, and unspecified erythematous conditions, occurring in the first 3 months of receiving allopurinol.

A total of 1 613 719 patients receiving allopurinol prescriptions were identified. During the study period, the percentage of patients receiving allopurinol for asymptomatic hyperuricemia increased from 36.7% to 49.5%, and the incidence of hypersensitivity reactions increased from 3.71 per 1000 new users to 6.12 per 1000 new users (p < 0.001). Comorbid chronic renal disease and comorbid cardiovascular disease were associated with increased risk of hypersensitivity (OR 1.49, 95%CI 1.38-1.61 and OR 1.13, 95%CI 1.04-1.22, respectively), and increased risk of mortality (OR 2.20 and OR 1.79, respectively). These associations remained significant when analyzed for patients receiving allopurinol for asymptomatic hyperuricemia.

Image: CC/Wiki

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adverse drug effects
Previous Post

2 Minute Medicine Rewind July 13 – July 19, 2015

Next Post

Bystander and first-responder initiated CPR associated with improved outcomes

RelatedReports

Migraine collage: a woman with her eyes closed and soft arcs radiating from her temple, a glass of water and a sleep mask
Neurology

Patient values and preferences when treating acute episodic migraine

March 26, 2025
Ophthalmology

Anti-VEGF therapy for retinopathy of prematurity may be associated with pulmonary hypertension risk

October 19, 2022
#VisualAbstract: CARG-BC score may predict risk of severe chemotherapy toxicity in elderly patients with early breast cancer
StudyGraphics

#VisualAbstract: CARG-BC score may predict risk of severe chemotherapy toxicity in elderly patients with early breast cancer

February 24, 2021
Chronic Disease

Comparison of 3 treatment strategies for medication overuse headache

June 7, 2020
Next Post

Bystander and first-responder initiated CPR associated with improved outcomes

Cognitive outcomes in older adults undergoing cardiovascular procedures unclear

Cognitive outcomes in older adults undergoing cardiovascular procedures unclear

Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients

Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways
  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.